Nivolumab-induced eosinophilic fasciitis: An unusual immune-related adverse event that needs to be recognized by practitioners.

Benzaquen, M; Christ, L; Sutter, N; Özdemir, B C (2023). Nivolumab-induced eosinophilic fasciitis: An unusual immune-related adverse event that needs to be recognized by practitioners. Annales de dermatologie et de vénéréologie, 150(4), pp. 304-307. Elsevier 10.1016/j.annder.2023.07.001

[img] Text
1-s2.0-S0151963823000704-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.
Download (739kB)

Item Type:

 Journal Article (Further Contribution)

Division/Institute:

 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology
04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology and Immunology
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology

UniBE Contributor:

 Benzaquen, Michael Joseph, Christ, Lisa Alexandra, Sutter, Nora, Özdemir, Berna

Subjects:

 600 Technology > 610 Medicine & health

ISSN:

 0151-9638

Publisher:

 Elsevier

Language:

 English

Submitter:

 Pubmed Import

Date Deposited:

 12 Oct 2023 14:04

Last Modified:

 10 Dec 2023 00:15

Publisher DOI:

 10.1016/j.annder.2023.07.001

PubMed ID:

 37821251

BORIS DOI:

 10.48350/187123

URI:

 https://boris.unibe.ch/id/eprint/187123

Actions (login required)

Edit item Edit item
Provide Feedback